Eyenovia Inc (NASDAQ: EYEN) kicked off on Monday, down -7.07% from the previous trading day, before settling in for the closing price of $0.10. Over the past 52 weeks, EYEN has traded in a range of $0.08-$2.57.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 100.00%. While this was happening, its average annual earnings per share was recorded 12.40%. With a float of $85.81 million, this company’s outstanding shares have now reached $86.38 million.
Considering the fact that the conglomerate employs 57 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is -4716.41%, operating margin of -109178.31%, and the pretax margin is -118845.16%.
Eyenovia Inc (EYEN) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Eyenovia Inc is 10.09%, while institutional ownership is 13.96%. The most recent insider transaction that took place on Aug 28 ’24, was worth 14,077. In this transaction Chief Executive Officer of this company bought 27,071 shares at a rate of $0.52, taking the stock ownership to the 109,998 shares. Before that another transaction happened on Aug 26 ’24, when Company’s Chief Executive Officer bought 50,000 for $0.57, making the entire transaction worth $28,500. This insider now owns 82,927 shares in total.
Eyenovia Inc (EYEN) Earnings and Forecasts
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.16 earnings per share (EPS), higher than consensus estimate (set at -0.17) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.12 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 12.40% per share during the next fiscal year.
Eyenovia Inc (NASDAQ: EYEN) Trading Performance Indicators
Take a look at Eyenovia Inc’s (EYEN) current performance indicators. Last quarter, stock had a quick ratio of 0.53. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 292.67.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.73, a number that is poised to hit -0.08 in the next quarter and is forecasted to reach -0.31 in one year’s time.
Technical Analysis of Eyenovia Inc (EYEN)
Compared to the last year’s volume of 2.32 million, its volume of 17.62 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 32.82%. Additionally, its Average True Range was 0.04.
During the past 100 days, Eyenovia Inc’s (EYEN) raw stochastic average was set at 0.88%, which indicates a significant decrease from 3.05% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 524.64% in the past 14 days, which was higher than the 233.96% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.4050, while its 200-day Moving Average is $0.8068. Nevertheless, the first resistance level for the watch stands at $0.0971 in the near term. At $0.1023, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.1057. If the price goes on to break the first support level at $0.0885, it is likely to go to the next support level at $0.0851. Should the price break the second support level, the third support level stands at $0.0799.
Eyenovia Inc (NASDAQ: EYEN) Key Stats
The company with the Market Capitalisation of 8.78 million has total of 86,442K Shares Outstanding. Its annual sales at the moment are 4 K in contrast with the sum of -27,260 K annual income. Company’s last quarter sales were recorded 20 K and last quarter income was -11,050 K.
